Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood · 1997 · 1.4K citations

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus

Hugues de Thé, Christine Chomienne, Michel Lanotte et al. · Nature · 1990 · 1.4K citations

Hematological Malignancy, Acute Promyelocytic Leukaemia, Mixed-phenotype Acute Leukemia +8

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

Steven L. Soignet, P. Maslak, Zhugang Wang et al. · New England Journal of Medicine · 1998 · 1.2K citations

Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

Ari Melnick, Jonathan D. Licht · Blood · 1999 · 1K citations

Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells

Miroslav Stýblo, Luz M. Del Razo, Libia Vega et al. · Archives of Toxicology · 2000 · 988 citations

Inorganic Chemistry, Biochemistry, Human Cells +12